[Evaluation of possible significant pharmacokinetic interactions between butizide and potassium canrenoate in man].
Regazzi
M B
MB
Farinelli
F
F
Corsico
G
G
Bré
E
E
Rampini
A
A
D000328:Adult; D002191:Canrenoic Acid / Q000493:pharmacokinetics*; D004232:Diuretics; D004347:Drug Interactions; D006801:Humans; D006852:Hydrochlorothiazide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D008297:Male; D011245:Pregnadienes / Q000493:pharmacokinetics*; D049993:Sodium Chloride Symporter Inhibitors / Q000493:pharmacokinetics*
D004232:Diuretics; D011245:Pregnadienes; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D002191:Canrenoic Acid; C009732:buthiazide
Valutazione di eventuali interazioni farmacocinetiche significative nell'uomo tra butizide e canrenoato di potassio.